Tab-Cel Gets EU Fast-Track Nod; Nefecon Reverts To Standard Review

Atara Plans November Filing As Calliditas Expects Three-Month Approval Decision Delay

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".